Grace Dent, the renowned restaurant critic, has spoken out against the use of weight-loss injections, expressing concerns that they could negatively impact her career. Dent, who has built a reputation for her honest and robust reviews, fears that losing weight might alter her professional persona and affect her job.
Her comments come amid a government-backed study exploring whether drugs like semaglutide and tirzepatide could help reduce unemployment and sick days among obese individuals. Prime Minister Sir Keir Starmer has suggested that such jabs could boost the economy by enabling people to return to work.
Health Secretary Wes Streeting highlighted that obesity costs the NHS £11 billion annually and leads to an average of four extra sick days per year per employee. However, experts caution that weight-loss drugs are not a panacea, as obesity often coexists with other medical conditions.
Dr Zofia Bajorek of the Institute for Employment Studies warned that workplace stigma against obesity may persist even after weight loss, potentially affecting recruitment and pay. She emphasized the need for comprehensive support for those entering employment.
Dent's stance reflects broader societal debates about the use of pharmaceutical aids for weight loss, with some viewing it as 'cheating'. The Mounjaro trial aims to assess the drugs' impact on employment, but concerns about NHS capacity and long-term effectiveness remain.
